# Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient

> **NCT02182895** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 72 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Saxagliptin

## Key facts

- **NCT ID:** NCT02182895
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182895, "Safety and Efficacy of Saxagliptin for Glycemic Control in Non-Critically Ill Hospitalized Patient". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02182895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*